Abstract:RNA interference (RNAi) is being evaluated as an alternative therapeutic strategy for hepatitis C virus (HCV) infection The use of viral vectors encoding short hairpin RNAs (shRNAs) has been the most common strategy employed to provide sustained expression of RNAi effectors However, overexpression and incomplete processing of shRNAs has led to saturation of the endogenous miRNA pathway, resulting in toxicity The use of endogenous microRNAs (miRNAs) as scaffolds for short interfering (siRNAs) may avoid these problems, and miRNA clusters can be engineered to express multiple RNAi effectors, a feature that may prevent RNAi-resistant HCV mutant generation We exploited the endogenous miRNA-17-92 duster to generate a polycistronic primary miRNA that is processed into five mature miRNAs that target different regions of the HCV genome All five anti-HCV miRNAs were active, achieving up to 97% inhibition of Renilla luciferase (RLuc) HCV reporter plasmids Self-complementary recombinant adeno-associated virus (scAAV) vectors were chosen for therapeutic delivery of the miRNA duster Expression of the miRNAs from scAAV inhibited the replication of cell culture propagated HCV (HCVcc) by 98%, and resulted in up to 93% gene silencing of RLuc-HCV reporter plasmids in mouse liver No hepatocellular toxicity was observed at scAAV doses as high as 5 x 10(11) vector genomes per mouse, a dose that is approximately five-fold higher than doses of scAAV-shRNA vectors that others have shown previously to be toxic in mouse liver Conclusion. We have demonstrated that exogenous anti-HCV miRNAs induce gene silencing, and when expressed from scAAV vectors inhibit the replication of HCVcc without inducing toxicity The combination of an AAV vector delivery system and exploitation of the endogenous RNAI pathway is a potentially viable alternative to current HCV treatment regimens (HEPATOLOGY 2010,52 1877-1887)

[Inhibition of HCV Replication by HCV Specific U1 Small Nuclear RNA Chimeric Ribozyme in Vivo].

Efficient Inhibition of Human Cytomegalovirus DNA Polymerase Expression by Small Hairpin RNA in Vitro

Efficient Inhibition of Human Cytomegalovirus UL122 Gene Expression in Cell by Small Interfering RNAs

Inhibition of HBV Core Antigen Gene Expression in Human Embryonic Kidney Cell Line AD293 by Plasmid-Based RNAi

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

[Construction of a full-genome HCV replicon with self-cleaving double ribozyme sequences and characterization in vitro and in vivo]

Inhibition of Dual-Target Ribozyme Against HBV on HBeAg in HHCC Cells

RNA Interference Effectively Inhibits Mrna Accumulation and Protein Expression of Hepatitis C Virus Core and E2 Genes in Human Cells

Inhibition of Hepatitis C Virus Replication by Single and Dual Small Interfering RNA Using an HCV-infected Cell Model

Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot

Sirna-Mediated Inhibition of Hbv Replication and Expression

Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication

Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme

Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells

Inhibition of Hepatitis C Virus Replication Using Adeno-Associated Virus Vector Delivery of an Exogenous Anti-Hepatitis C Virus Microrna Cluster

Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics

Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered external guide sequences.

Inhibition of hepatitis C virus serine protease in living cells by RNA aptamers detected using fluorescent protein substrates

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA